Jane Street’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Jane Street’s Portfolio PEAR Stock Details PEAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-44,943	Closed	-$53K	–	10377
2022 Q4	$53K	Buy	+44,943	New	+$94.5K	﹤0.01%	8348
2022 Q2	–	Sell	-32,352	Closed	-$163K	–	11350
2022 Q1	$163K	Buy	+32,352	New	+$147K	﹤0.01%	9179
2021 Q4	–	Sell	-30,217	Closed	-$300K	–	11062
2021 Q3	$300K	Sell	30,217 -6,389	-17%	-$63.2K	﹤0.01%	8185
2021 Q2	$362K	Buy	36,606 +11,706	+47%	+$115K	﹤0.01%	7835
2021 Q1	$241K	Buy	+24,900	New	+$241K	﹤0.01%	8013

Other funds holding PEAR

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return

Arboretum Ventures Ann Arbor, Michigan $1.72M AUM 82.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TAA

TB Alternative Assets Grand Cayman, Cayman Islands $623M AUM 154.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Jane Street's PEAR Position: Q1 2023 in Review

Jane Street sold out of Pear Therapeutics, Inc. Class A Common Stock (PEAR) in Q1 2023, closing a stake of 44,943 shares — an estimated $53K sold.

Jane Street first reported a position in PEAR in Q1 2021 and held it in 5 quarters. The position peaked at $362K in Q2 2021. 53 funds tracked by Wall St. Rank hold PEAR as of Q1 2023.

Jane Street reported no remaining Pear Therapeutics, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
Jane Street sold 44,943 Pear Therapeutics, Inc. Class A Common Stock shares in Q1 2023, an estimated $53K.
Jane Street first reported a position in Pear Therapeutics, Inc. Class A Common Stock in Q1 2021 and held it in 5 quarters.
Jane Street's Pear Therapeutics, Inc. Class A Common Stock position peaked at $362K in Q2 2021.
53 funds tracked by Wall St. Rank held Pear Therapeutics, Inc. Class A Common Stock as of Q1 2023.

Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.